SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 200 filers reported holding SAGE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,510,000 | -85.2% | 226,679 | -62.8% | 0.07% | -77.5% |
| Q4 2019 | $43,945,000 | +7993.0% | 608,741 | +15613.5% | 0.32% | +8025.0% |
| Q3 2019 | $543,000 | -98.9% | 3,874 | -98.5% | 0.00% | -98.9% |
| Q2 2019 | $47,736,000 | +15.9% | 260,725 | +0.7% | 0.36% | +22.9% |
| Q1 2019 | $41,174,000 | +957.6% | 258,877 | +372.6% | 0.29% | +910.3% |
| Q1 2017 | $3,893,000 | -3.0% | 54,781 | -30.3% | 0.03% | -6.5% |
| Q4 2016 | $4,015,000 | -61.9% | 78,641 | -65.7% | 0.03% | -63.1% |
| Q3 2016 | $10,543,000 | – | 228,954 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |